Insider Transactions in Q4 2022 at Acumen Pharmaceuticals, Inc. (ABOS)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2022
|
Matt Zuga CFO & Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+39.62%
|
$50,000
$1.19 P/Share
|